Hanmi Science stock: Q3 sales rise as profit falls sharply

Published on 10/30/2026 at 02:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hanmi Science stock saw third-quarter sales rise while profit fell sharply. The results highlight a widening gap between growth and earnings.

Third-quarter results show mixed performance

Revenue increased 5.9 percent year over year to KRW 362.9 billion.
Operating profit fell 51.3 percent to KRW 19.2 billion, while net income declined 51.1 percent to KRW 15.6 billion.
The results underline stronger sales alongside substantial earnings pressure.

Hanmi Science, KR7008930000, Illustration mit AI erstellt.

Hanmi Science reported mixed third-quarter results on October 27, with revenue increasing but profitability declining sharply. The figures were reported by Yonhap News Agency based on the companys regulatory filing.

Sales growth does not reach earnings

For the July-to-September period, Hanmi Science recorded revenue of KRW 362.9 billion, up 5.9 percent from the same period a year earlier. Operating profit, however, dropped 51.3 percent to KRW 19.2 billion, while net income fell 51.1 percent to KRW 15.6 billion.

For investors, the results present a mixed picture. Top-line growth indicates continued business activity, but the simultaneous decline in operating profit and net income shows that higher sales did not translate into comparable earnings momentum during the quarter.

What investors should watch

The third-quarter figures make margin development and the quality of future revenue growth important areas to monitor. The reported earnings decline also means that sales expansion alone may not be sufficient to improve the companys near-term investment profile.

For a live market view, see the real-time quote of Hanmi Science stock.

The South Korean market environment can be followed through the KOSPI market overview.

For additional company coverage, see More news and analyses on Hanmi Science stock.